Nolato ABFRA:NBF 82 Interest Coverage is 13.89 as of Mar. 2026, which is 55% below its 10-year median of 30.55. GuruFocus rates FRA:NBF with a GF Score™ of 82/100 and a GF Value™ of €4.74 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Nolato AB ranks better than 54.29% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Nolato AB's
Operating Income
for the
three
months ended in Mar. 2026 was €23.2 Mil. Nolato AB's Interest Expense for the
three
months ended in Mar. 2026 was €-1.7 Mil.
Nolato AB's interest coverage for the quarter that ended in Mar. 2026 was 13.89.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Nolato AB's Interest Coverage or its related term are showing as below:
FRA:NBF'
s Interest Coverage Range Over the Past 10 Years
Min: 11.58 Med: 30.55 Max: 117.13
Current: 19.88
FRA:NBF's Interest Coverage is ranked better than 54.29% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs FRA:NBF: 19.88
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Nolato AB Interest Coverage Related Terms
Nolato AB Interest Coverage Historical Data
* Premium members only.
The historical data trend for Nolato AB's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
FRA:NBF vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Nolato AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nolato AB Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Nolato AB's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nolato AB (FRA:NBF) has a Interest Coverage of 13.89 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Nolato AB and its competitors. This is 55% below median its historical median of 30.55. Over the past decade, Nolato AB's Interest Coverage has ranged from 11.58 to 117.13. According to the industry distribution chart, Nolato AB ranks #213 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 45.7%.
Is Nolato AB's Interest Coverage too high?
Nolato AB's current Interest Coverage of 13.89 is 55% below median its 10-year median of 30.55. Over the past 10 years, this metric has ranged from a low of 11.58 to a high of 117.13. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Nolato AB's value of 13.89 is 12.5% below this industry median. Based on the distribution chart, Nolato AB ranks #213 out of 466 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nolato AB has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nolato AB ranks #213 out of 466 companies for Interest Coverage. This puts Nolato AB in the upper half of its industry. The industry median Interest Coverage is 15.88. Nolato AB's value of 13.89 is 12.5% below this benchmark. Historically, Nolato AB's own Interest Coverage has ranged from 11.58 to 117.13 over the past decade. While the company's 10-year median is 30.55 vs. the industry median of 15.88, Nolato AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nolato AB's current Interest Coverage of 13.89 is 12.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Nolato AB and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nolato AB's current Interest Coverage is 13.89, which is 55% below median its own 10-year median of 30.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Based on GuruFocus' analysis, Nolato AB (FRA:NBF) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.74, compared to a current price of €4.28 — trading 9.8% below its estimated fair value. The current Interest Coverage is 13.89, which is 55% below median its 10-year median of 30.55 and 12.5% below the Medical Devices & Instruments industry median of 15.88. Nolato AB's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Nolato AB (FRA:NBF), the current Interest Coverage is 13.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nolato AB (FRA:NBF) Overvalued in 2026?
Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued.
The current stock price of €4.28 is trading 9.8% below its estimated GF Value™ of €4.74.
GuruFocus considers Nolato AB to be Modestly Undervalued.
Key valuation signals for FRA:NBF:
Interest Coverage: 13.89 (55% below median its 10-year median of 30.55)
GF Value™: €4.74 vs. price of €4.28 (9.8% below fair value)
Industry Position: 12.5% below the Medical Devices & Instruments median (#213 of 466)
No single metric tells the full story. See the FRA:NBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
82GF Score
Get the complete analysis for FRA:NBF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NBF has been successfully added to your 
